drugset / Trial / NCT03903549
Initial Investigation of [18F]P17-059 in Parkinson's Disease Patients and Healthy Volunteers
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
This study investigates the initial safety profile of \[18F\]P17-059 in healthy volunteers including dosimetry determination, and compares regional brain uptake and kinetics of \[18F\]P17-059 in Parkinson's disease patients with regional brain uptake and kinetics of \[18F\]P17-059 in healthy volunteers.
Timeline
- Start
- 2022-07-15
- Primary completion
- 2022-12-19
- Completion
- 2022-12-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [18F]P17-059 | Unknown | 10 unknown | Other |